Alterity Therapeutics annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Alterity Therapeutics Current Ratio Growth & History (ATHE)
Alterity Therapeutics's current ratio was 14.52 for fiscal 2026.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | 14.52 | 1.54 | +11.89% |
| 2025 | 2025-06-30 | 12.98 | 9.43 | +266.33% |
| 2024 | 2024-06-30 | 3.54 | −2.63 | −42.61% |
| 2023 | 2023-06-30 | 6.17 | −0.90 | −12.68% |
| 2022 | 2022-06-30 | 7.07 | −3.85 | −35.25% |
| 2021 | 2021-06-30 | 10.92 | 7.29 | +201.27% |
| 2020 | 2020-06-30 | 3.62 | −2.36 | −39.42% |
| 2019 | 2019-06-30 | 5.98 | −1.07 | −15.22% |
| 2018 | 2018-06-30 | 7.06 | −8.82 | −55.56% |
| 2017 | 2017-06-30 | 15.88 | — | — |
Alterity Therapeutics quarterly current ratio
Q4.17
Q4.18
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | 14.52 | 1.54 | +11.89% |
| Q2 2026 | 2025-12-31 | 21.98 | 18.14 | +472.63% |
| Q4 2025 | 2025-06-30 | 12.98 | 9.43 | +266.33% |
| Q2 2025 | 2024-12-31 | 3.84 | — | — |
| Q4 2024 | 2024-06-30 | 3.54 | −2.63 | −42.61% |
| Q4 2023 | 2023-06-30 | 6.17 | −0.90 | −12.68% |
| Q4 2022 | 2022-06-30 | 7.07 | −3.85 | −35.25% |
| Q2 2022 | 2021-12-31 | 11.92 | −0.36 | −2.93% |
| Q4 2021 | 2021-06-30 | 10.92 | 7.29 | +201.27% |
| Q2 2021 | 2020-12-31 | 12.28 | — | — |
| Q4 2020 | 2020-06-30 | 3.62 | −2.36 | −39.42% |
| Q4 2019 | 2019-06-30 | 5.98 | −1.07 | −15.22% |
| Q4 2018 | 2018-06-30 | 7.06 | −8.82 | −55.56% |
| Q4 2017 | 2017-06-30 | 15.88 | — | — |
Alterity Therapeutics current ratio trends
Over the last five fiscal years, Alterity Therapeutics's current ratio increased from 10.92 to 14.52, a change of 3.60. The latest reported quarter, Q4 2026, shows 14.52.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics source filings ↗